Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.65 |
| ▸ | NAAA | Q02083 | 3/20 | 0.57 |
| ▸ | CASP2 | P42575 | 1/20 | 0.54 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27527714 | 1.00 | HPGD (0.65) | HPGDNAAACASP2MTNR1AHSD17B10 | |
| SCHEMBL6807560 | 0.87 | HPGD (0.48) | HPGDTRPV1 | |
| SCHEMBL6800326 | 0.86 | TAAR1 (0.49) | HPGD | |
| SCHEMBL5404064 | 0.86 | LMNA (0.57) | HPGDTRPV1 | |
| SCHEMBL10038330 | 0.85 | NAAA (0.60) | HPGDNAAAHSD17B10TRPV1 | |
| SCHEMBL12980401 | 0.85 | NAAA (0.60) | HPGDNAAAHSD17B10TRPV1 | |
| SCHEMBL8518455 | 0.84 | NAAA (0.58) | NAAA | |
| SCHEMBL27397541 | 0.84 | EP300 (0.50) | MTNR1AMEN1MAPTKMT2A | |
| SCHEMBL6808007 | 0.83 | BCHE (0.47) | HPGDMAPT | |
| Hydrochloric Acid SCHEMBL7769515 | 0.83 | HPGD (0.62) | HPGDNAAACASP2MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5954844-A | BACKING SUPPORTING SURFACE-BOUND ABRASIVE PARTICLES AND ANTILOADING COMPOUND COMPRISING AN ALKYLATED OR FLUOROALKYLATED ORGANOBORON, ORGANONITROGEN, ORGANOPHOSPHORUS, ORGANOSULFUR, OR HYDROXYCARBOXYLIC ACID DERIVATIVE | MINNESOTA MINING & MANUFACTURING COMPANY (US) | 1999-09-21 | — | — | US | claimed |
| EP-0912295-A1 | ABRASIVE ARTICLE COMPRISING AN ANTILOADING COMPONENT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-05-06 | — | — | EP | claimed |
| US-5704952-A | COATINGS, BONDING, NONWOVEN ABRASIVES AND BINDERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-01-06 | — | — | US | claimed |
| WO-1997042007-A1 | ABRASIVE ARTICLE COMPRISING AN ANTILOADING COMPONENT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-11-13 | — | — | WO | claimed |
| EP-1026150-B1 | (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same | SHISEIDO CO LTD (JP) | 2011-06-29 | — | — | EP | disclosed |
| US-6573297-B2 | Applying an effective amount of (2-substituted oxyphenyl)alkanamide derivatives to the skin of a mammal for promoting hair growth | SHISEIDO CO., LTD. (JP) | 2003-06-03 | — | — | US | disclosed |
| US-20020052498-A1 | (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same | SHISEIDO CO., LTD. (JP) | 2002-05-02 | — | — | US | disclosed |
| US-6339154-B1 | THERAPY OF HAIR LOSS IN MAMMALS AND, IN PARTICULAR, IN HUMAN | SHISEIDO CO, LTD. (JP) | 2002-01-15 | — | — | US | disclosed |
| CN-1271724-A | (2-substituted oxyphenyl) alkane acylamide derivative and hair nourishing agent, skin external use agent | SHISEIDO CO LTD (JP) | 2000-11-01 | — | — | CN | disclosed |
| EP-1026150-A1 | (2-oxy substituted)-phenylalkanamide derivative, hair growth promoter and external composition for skin using the same | SHISEIDO COMPANY LIMITED (JP) | 2000-08-09 | — | — | EP | disclosed |
| US-5954844-A | BACKING SUPPORTING SURFACE-BOUND ABRASIVE PARTICLES AND ANTILOADING COMPOUND COMPRISING AN ALKYLATED OR FLUOROALKYLATED ORGANOBORON, ORGANONITROGEN, ORGANOPHOSPHORUS, ORGANOSULFUR, OR HYDROXYCARBOXYLIC ACID DERIVATIVE | MINNESOTA MINING & MANUFACTURING COMPANY (US) | 1999-09-21 | — | — | US | disclosed |
| EP-0912295-A1 | ABRASIVE ARTICLE COMPRISING AN ANTILOADING COMPONENT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1999-05-06 | — | — | EP | disclosed |
| US-5704952-A | COATINGS, BONDING, NONWOVEN ABRASIVES AND BINDERS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1998-01-06 | — | — | US | disclosed |
| WO-1997042007-A1 | ABRASIVE ARTICLE COMPRISING AN ANTILOADING COMPONENT | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1997-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020052498-A1 | (2-substituted oxyphenyl)alkanamide derivative, hair growth promoter and external composition for skin using the same | NR2E1, NCOR2, DECR2 | HPGD 3125/4885NAAA 1537/4885CASP2 2271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.